Drug General Information
Drug ID
D0PR9E
Former ID
DNC006484
Drug Name
KMI-596
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530840]
Structure
Download
2D MOL

3D MOL

Formula
C34H45N7O9
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C3=NC<br />(=O)ON3)O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)N
InChI
1S/C34H45N7O9/c1-18(2)15-25(38-32(47)27(19(3)4)39-30(45)23(35)13-14-26(42)43)31(46)37-24(16-20-9-6-5-7-10-20)28(44)33(48)36-22-12-8-11-21(17-22)29-40-34(49)50-41-29/h5-12,17-19,23-25,27-28,44H,13-16,35H2,1-4H3,(H,36,48)(H,37,46)(H,38,47)(H,39,45)(H,42,43)(H,40,41,49)/t23-,24-,25-,27-,28+/m0/s1
InChIKey
WXPDDAQNFBWSRN-WZFFGLSISA-N
PubChem Compound ID
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [530840]
References
Ref 530840Bioorg Med Chem. 2010 May 1;18(9):3175-86. Epub 2010 Mar 21.Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
Ref 530840Bioorg Med Chem. 2010 May 1;18(9):3175-86. Epub 2010 Mar 21.Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.